Medpace Holdings, Inc.
NASDAQ:MEDP
319.56 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,885.842 | 1,459.996 | 1,142.377 | 925.925 | 860.969 | 704.589 | 436.152 | 421.582 | 359.059 | 290.041 | 272.89 |
| Cost of Revenue
| 1,361.337 | 1,027.558 | 814.222 | 647.199 | 615.272 | 489.059 | 261.463 | 249.471 | 202.665 | 156.309 | 148.399 |
| Gross Profit
| 524.505 | 432.438 | 328.155 | 278.726 | 245.697 | 215.53 | 174.689 | 172.111 | 156.394 | 133.732 | 124.491 |
| Gross Profit Ratio
| 0.278 | 0.296 | 0.287 | 0.301 | 0.285 | 0.306 | 0.401 | 0.408 | 0.436 | 0.461 | 0.456 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 159.852 | 130.1 | 107.221 | 91.456 | 94.545 | 75.681 | 63.357 | 61.507 | 56.598 | 39.368 | 34.809 |
| Selling & Marketing Expenses
| 1.5 | 1.3 | 1.2 | 0.7 | 0.7 | 0.8 | 0.6 | 0.6 | 0.4 | 0.3 | 0.3 |
| SG&A
| 161.352 | 131.4 | 108.421 | 92.156 | 95.245 | 75.681 | 63.357 | 61.507 | 56.998 | 39.668 | 35.109 |
| Other Expenses
| 1.274 | 22.341 | 21.119 | 19.528 | 23.189 | 1.06 | -0.354 | -0.423 | 0.174 | 0 | 2.393 |
| Operating Expenses
| 187.68 | 153.741 | 129.54 | 111.684 | 118.434 | 114.482 | 109.831 | 119.621 | 126.519 | 128.536 | 65.628 |
| Operating Income
| 336.825 | 278.697 | 198.615 | 167.042 | 127.263 | 101.048 | 64.858 | 52.49 | 33.075 | 26.001 | 58.863 |
| Operating Income Ratio
| 0.179 | 0.191 | 0.174 | 0.18 | 0.148 | 0.143 | 0.168 | 0.142 | 0.103 | 0.09 | 0.241 |
| Total Other Income Expenses Net
| -1.143 | 4.163 | 3.237 | 1.49 | -2.431 | -7.097 | -7.913 | -30.533 | -40.905 | -47.262 | -19.718 |
| Income Before Tax
| 335.682 | 282.86 | 201.852 | 168.532 | 124.832 | 93.951 | 56.945 | 21.957 | -7.83 | -21.261 | 39.145 |
| Income Before Tax Ratio
| 0.178 | 0.194 | 0.177 | 0.182 | 0.145 | 0.133 | 0.147 | 0.059 | -0.024 | -0.073 | 0.16 |
| Income Tax Expense
| 52.872 | 37.492 | 20.004 | 23.148 | 24.389 | 20.766 | 17.823 | 8.532 | 0.843 | 5.689 | 14.301 |
| Net Income
| 282.81 | 245.211 | 181.39 | 144.925 | 100.164 | 72.894 | 39.032 | 13.392 | -8.673 | -15.572 | 24.844 |
| Net Income Ratio
| 0.15 | 0.168 | 0.159 | 0.157 | 0.116 | 0.103 | 0.101 | 0.036 | -0.027 | -0.054 | 0.102 |
| EPS
| 9.2 | 7.57 | 5.06 | 4.07 | 2.79 | 2.05 | 1 | 0.38 | -0.28 | -0.53 | 1.33 |
| EPS Diluted
| 8.88 | 7.28 | 4.81 | 3.84 | 2.67 | 1.97 | 0.98 | 0.37 | -0.28 | -0.53 | 1.28 |
| EBITDA
| 365.082 | 301.038 | 219.734 | 186.57 | 150.452 | 140.909 | 110.978 | 110.181 | 99.57 | 94.064 | 91.775 |
| EBITDA Ratio
| 0.194 | 0.206 | 0.192 | 0.201 | 0.175 | 0.2 | 0.254 | 0.261 | 0.277 | 0.324 | 0.336 |